Rosetta Genomics Ltd. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Rosetta Genomics Ltd. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $1.26 million for the 6-month period ending 2017-06-30, per its 6-K filed 2017-10-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-10-10
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-06-30 | $1.26M 6-K · filed 2017-10-10 | |
| 2016-12-31 | $3.26M 6-K · filed 2017-10-10 | |
| 2016-06-30 | $0.00 6-K · filed 2017-10-10 | |
| 2015-12-31 | $17.32M 6-K · filed 2017-10-10 | |
| 2015-06-30 | $9.34M 6-K · filed 2016-09-26 | |
| 2014-12-31 | $5.01M 6-K · filed 2017-10-10 | |
| 2014-06-30 | $2.96M 6-K · filed 2015-10-26 | |
| 2013-12-31 | $4.74M 6-K · filed 2016-12-08 | |
| 2013-06-30 | $2.86M 6-K · filed 2013-09-09 | |
| 2012-12-31 | $38.92M 20-F · filed 2014-03-31 | |
| 2012-06-30 | $10.65M 6-K · filed 2013-09-09 | |
| 2011-12-31 | $9.56M 20-F · filed 2014-03-31 | |
| 2011-06-30 | $4.93M 6-K · filed 2012-09-28 | |
| 2010-12-31 | $6.98M 20-F · filed 2013-03-22 | |
| 2009-12-31 | $6.42M 6-K · filed 2012-12-07 |